Su Liu

Su Liu has a diverse work experience in the field of science and research. Starting in 2010, Su Liu worked as a Postdoctoral Fellow at the Buck Institute for Research on Aging until 2016. Then, from 2016 to 2021, Su Liu worked at BioMarin Pharmaceutical Inc., initially as a Scientist I, and later as a Scientist II. In 2021, Su Liu joined Ambys Medicines as a Senior Scientist II, before moving on to Astellas Gene Therapies, where they currently hold the position of Senior Scientist.

Su Liu attended the University of Rochester School of Medicine and Dentistry, but no further information regarding the degree earned or field of study was provided.